- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02372851
Assessing the Effectiveness of a Water Filter Technology as an Arsenic Mitigation Strategy in West Bengal
Assessing the Effectiveness of a Point-of-use Water Filter Technology as an Arsenic Mitigation Strategy in West Bengal
Study Overview
Status
Intervention / Treatment
Detailed Description
The Unilever Pureit As+ filter will be assessed for chemical and microbiological performance and health impact using a parallel, household-randomised controlled trial (RCT) design over a four-month follow-up period.
This study will follow an open (non-blinded) design because filtration technologies are particularly challenging to blinding (Boisson et al., 2010). Equal randomisation will be applied (i.e. 1:1). Randomisation will be undertaken through a lottery organised in each participating village.
The study will be undertaken in two phases; an initial phase will involve a baseline survey in the identified affected communities. Those households identified as eligible during the baseline survey will then be randomised into the intervention or control group and the intervention will then be distributed. After a 2-4 week adaptation period, control and intervention arms will be followed at monthly visits for a period of four months.
The baseline study will collect information on demographics, sanitation facilities, hygiene practices, drinking water sources and treatment practices, diet of household members, knowledge of arsenic contamination and arsenicosis, and other factors that could potentially impact the outcomes of interest. Additionally, data on behavioural factors that have been observed to be associated with Household Water Treatment (HWT) use will be collected to predict intervention use in the intervention arm. During the baseline survey, water samples of source water and stored drinking water will be collected and tested for total thermotolerant coliforms (TTC) and total arsenic concentration. The female head of the household will be invited to provide a sample of urine for total urinary arsenic testing. The female head of the household will be followed because it is expected that she will be the household member that i. is mainly responsible for drinking water management, and ii. is at home most of the day and thus making it logistically feasible to obtain spot urine samples throughout the study.
At monthly intervals, participating households will be visited to assess filter use using self report as well as objective indicators. Additionally, in each round of follow-up, drinking water samples will be taken in all participating households for both microbiological and arsenic testing. Additionally, the female head of household will be invited to provide spot urine samples for total urinary arsenic at each round of follow up.
For arsenic testing samples of stored drinking water will be collected and analysed for total arsenic. Additionally, in intervention households, samples of source water will also be collected to assess the percentage removal of Arsenic by the Pureit AS+ filter. Water samples will be collected in polyethylene bottles pre-washed with nitric acid water and nitric acid (0.1% v/v) will be added after collection at the laboratory as a preservative (Roychowdhury, 2008). Samples will be stored in ice box until arrival to the lab and stored at 4°C until shipment to the laboratory for analysis. Total water arsenic will be measured by Flow Injection Hydride Generation Atomic Absorption Spectrometry (FI-HG-AAS) and or Inductively coupled plasma mass spectrometry (ICP-MS).
For microbiological testing, in each round of follow-up, in intervention households water samples will be collected of i. stored drinking water (whether this is from the intervention filter or another container), ii. in a 25% random sample, samples will also be taken of influent water (source water) and effluent water out of the filter (if they keep their drinking water elsewhere). For control households, water samples will be collected of i. stored drinking water and, ii. in a 25% random sample, from the water source. Untreated drinking water will be collected to determine technology performance by comparing effluent and influent water quality. For the stored drinking water, the householder will be asked if there is any drinking water in the house at that moment and a sample will be collected from the vessel that the householder identifies as being the main container used at that moment to fill a cup or glass for drinking. All samples for microbial analysis will be collected in sterile Whirl-Pak™ bags containing a tablet of sodium thiosulfate to neutralize any disinfectant. Samples will be placed on ice and processed within 4-6 hours of collection to assess TTC levels. Microbiological assessment will be performed using a DelAgua field incubator (University of Surrey) in accordance with Standard Methods (Eaton et al., 2005).
Acceptability and major limitations with the filtration technology will be assessed during the final follow-up visit. The acceptability of the technology will be evaluated by conducting household surveys, in-depth interviews (IDI) and focus group discussions (FGDs). A subsample of male and female heads of households will be asked to participate in FGDs at the end of the study to provide feedback on the technology including perceived benefits and limitations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Bengal
-
Gobardanga, North 24 Parganas, West Bengal, India
- Gobardanga Seba Farmer's Samity (GSFS)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Pureit As+ Filter
Each household will receive one water filter and a replacement battery for free during distribution.
The intervention will be distributed door-to-door by the implementation team.
Households will be trained on use and maintenance of the device according to the manufacturer's instructions.
Households will be advised to drink exclusively from the water filter and to carry water with them if attending school or work.
Households will also be advised to clean and cook their rice with filtered water only.
|
The Pureit As+ water filter has been developed to effectively remove arsenic (both arsenite and arsenate) from over 300 µg/L to less than 10 µg/L in addition to removing microbial contamination (Institution of Public Health Engineers, 2011).
It has an end-of-life indicator and consumables that do not re-contaminate the environment when disposed (Institution of Public Health Engineers, 2011).
The technology requires no electricity, but only the replacement of the battery after 1000 L of water filtered (approximately 100 days based on a family of five drinking 2 L/day).
|
|
NO_INTERVENTION: Control arm
The control arm will be advised to continue with their traditional drinking water and cooking practices.
The control arm will receive the intervention at the end of the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total urinary arsenic
Time Frame: 4 months
|
To assess the effectiveness of the Unilever Pureit As+ technology in decreasing the body burden of arsenic, measured in terms of total urinary arsenic
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total arsenic removal in drinking water
Time Frame: 4 months
|
Median and arithmetic mean of total arsenic concentration in intervention vs. control households stored drinking water
|
4 months
|
|
Total arsenic reduction in filtered water
Time Frame: 4 months
|
To assess total arsenic removal performance in drinking water of the Unilever Pureit As+ technology in the field (Mean % removal).
|
4 months
|
|
Mean TTC reduction in drinking water
Time Frame: 4 months
|
Williams mean of CFU/100 mL in intervention vs. control household stored drinking water
|
4 months
|
|
Self-reported use of the intervention
Time Frame: 4 months
|
To examine consistent use of Unilever Pureit As+ technology, for children <5 years and all household members
|
4 months
|
|
Consistent use
Time Frame: 4 months
|
To examine consistent use of Unilever Pureit As+ technology using objective indicators of use
|
4 months
|
|
Prevalence of diarrhoea among <5s
Time Frame: 4 months
|
To examine the impact of the Unilever Pureit As+ technology on reported diarrhoea among children under 5 years
|
4 months
|
|
Prevalence of diarrhoea among all family members
Time Frame: 4 months
|
5) To examine the impact of the Unilever Pureit As+ technology on reported diarrhoea among all family members.
|
4 months
|
|
Bacterial removal
Time Frame: 4 months
|
Mean % removal (log reduction) of TTC for intervention households
|
4 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LondonSHTM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diarrhoeal Disease
-
International Centre for Diarrhoeal Disease Research...CompletedDiarrhoeal DiseaseBangladesh
-
Centre for Infectious Disease Research in ZambiaImperial College London; Christian Medical College, Vellore, IndiaCompletedDiarrhoeal DiseaseZambia
-
London School of Hygiene and Tropical MedicineCentre for Infectious Disease Research in Zambia; Absolute Return for KidsCompleted
-
London School of Hygiene and Tropical MedicineEmory University; Oregon Health and Science University; University of Colorado... and other collaboratorsCompletedPneumonia | Respiratory Infection | Diarrhoeal DiseaseRwanda
-
London School of Hygiene and Tropical MedicineKenya Medical Research Institute; Jomo Kenyatta University of Agriculture and... and other collaboratorsCompletedDiarrhoeal Disease | Hookworm Infection | Trichuris Infection | Ascaris Lumbricoides Infection | TungiasisKenya
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
RenJi HospitalNot yet recruitingAutoinflammatory Disease | Still Disease
-
Aveiro UniversityPrograma Operacional Inclusão Social e Emprego (POISE); Programa Operacional... and other collaboratorsCompletedLung Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Interstitial Lung Disease | Chronic Respiratory DiseasePortugal
Clinical Trials on Pureit As+ Filter
-
National University Hospital, SingaporeCompletedHemorrhage | Acute Kidney Injury | CoagulopathySingapore
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedComplication of HemodialysisItaly
-
Aquora Research & Consulting, LLCSawyer Products, Inc; The Bucket Ministry; Sparrow Data SolutionsCompleted
-
Mohd Zulfakar Mazlan, MBBSRecruitingPneumonia | AKI - Acute Kidney InjuryMalaysia
-
University of Southern CaliforniaDuke UniversityRecruiting
-
Inha University HospitalCompletedChronic Kidney Diseases | Particulate MatterKorea, Republic of
-
Johnson & Johnson Vision Care, Inc.CompletedPhotosensitivityUnited States
-
University of AarhusRhinix ApSCompletedSeasonal Allergic RhinitisDenmark
-
University of AarhusSpirare ApSCompletedRhinitis, Allergic, SeasonalDenmark
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS)RecruitingAsthma in ChildrenUnited States